Strata Critical Medical, Inc.

SecuritySRTA / Strata Critical Medical, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,617,104 shares
Latest Disclosed Value $ 6,758,577
Dimensional Fund Advisors Lp reports 11.91% increase in ownership of SRTA / Strata Critical Medical, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,617,104 shares of Strata Critical Medical, Inc. (US:SRTA) valued at $6,759,495 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,444,950 shares of Strata Critical Medical, Inc.. This represents a change in shares of 11.91% during the quarter. The current value of the position is $10,042,216 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F STRATA CRITICAL MEDICAL CL A COM 092667104 1,617,104 172,154 11.91 6,759 -2.76 0.0003
2026-02-12 2025-12-31 13F STRATA CRITICAL MEDICAL CL A COM 092667104 1,444,950 -380,615 -20.85 6,950 -24.76 0.0015
2025-11-12 2025-09-30 13F STRATA CRITICAL MEDICAL CL A COM 092667104 1,825,565 -96,218 -5.01 9,238 19.26 0.0020
2025-08-12 2025-06-30 13F BLADE AIR MOBILITY CL A COM 092667104 1,921,783 24,494 1.29 7,745 49.55 0.0018
2025-05-13 2025-03-31 13F BLADE AIR MOBILITY CL A COM 092667104 1,897,289 374,499 24.59 5,180 -19.98 0.0013
2025-02-13 2024-12-31 13F BLADE AIR MOBILITY CL A COM 092667104 1,522,790 218,985 16.80 6,472 68.85 0.0016
2024-11-07 2024-09-30 13F BLADE AIR MOBILITY CL A COM 092667104 1,303,805 365,949 39.02 3,833 17.47 0.0009
2024-08-09 2024-06-30 13F BLADE AIR MOBILITY CL A COM 092667104 937,856 181,630 24.02 3,264 51.42 0.0009
2024-05-10 2024-03-31 13F BLADE AIR MOBILITY CL A COM 092667104 756,226 174,451 29.99 2,155 4.97 0.0006
2024-02-07 2023-12-31 13F BLADE AIR MOBILITY CL A COM 092667104 581,775 305,287 110.42 2,054 186.73 0.0006
2023-11-09 2023-09-30 13F BLADE AIR MOBILITY CL A COM 092667104 276,488 276,488 716 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.